In the wake of the increase in Current Liabilities in the fourth quarter 2026, Quick Ratio fell to 0.2 a new company low.

Within In Vitro & In Vivo Diagnostic Substances industry 12 other companies have achieved higher Quick Ratio than Neogen in fourth quarter 2026. While Quick Ratio total ranking in the fourth quarter 2026 has deteriorated compared to the prior quarter from 1661 to 3377.

Explain Quick Ratio?
How much Cash & cash equivalents NEOG�s has?
What are NEOG�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NEOG Quick Ratio	(May 31 2026) Q4	(Feb 28 2026) Q3	(Nov 30 2025) Q2	(Aug 31 2025) Q1	(May 31 2025) Q4
Y / Y Current Liabilities Change	443.15 %	6.66 %	12.76 %	19.17 %	17.17 %
Y / Y Cash & cash equivalent Change	43.79 %	25.21 %	-24.53 %	15.28 %	-24.53 %
Quick Ratio MRQ	0.2	1.06	0.74	0.95	0.76
NEOG's Total Ranking	# 3377	# 1661	# 17	# 28	# 1095
Seq. Current Liabilities Change	508.83 %	-13.45 %	19.02 %	-13.39 %	19.56 %
Seq. Cash & cash equivalent Change	16.01 %	23.95 %	-7.11 %	7.66 %	1.02 %

Quick Ratio fourth quarter 2026 Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 13
Healthcare Sector	# 823
Overall Market	# 3377

Quick Ratio Statistics
High	Average	Low
8.38	4.17	0.2
(Feb 29 2020)		(May 31 2026)

Financial Statements
Neogen's Current Liabilities	$ 917 Millions	Visit NEOG's Balance sheet
Neogen's Cash & cash equivalent	$ 186 Millions	Visit NEOG's Balance sheet
Source of NEOG's Sales		Visit NEOG's Sales by Geography

Cumulative Neogen's Quick Ratio

NEOG's Quick Ratio for the trailling 12 Months

NEOG Quick Ratio	(May 31 2026) 12 Months	(Feb 28 2026) 12 Months	(Nov 30 2025) 12 Months	(Aug 31 2025) 12 Months	(May 31 2025) 12 Months
Y / Y Current Liabilities TTM Growth	136.4 %	13.75 %	8.86 %	7.1 %	0.26 %
Y / Y Cash & cash equivalent TTM Growth	11.89 %	-5.64 %	-16.84 %	-19.69 %	-33.5 %
Quick Ratio TTM	0.44	0.87	0.83	0.93	0.93
Total Ranking TTM	# 3959	# 979	# 60	# 96	# 2716
Seq. Current Liabilities TTM Growth	116.96 %	1.49 %	3.22 %	4.01 %	4.4 %
Seq. Cash & cash equivalent TTM Growth	10.15 %	6.14 %	-7.4 %	3.36 %	-7.11 %

Quick ratio ranking by company, industry and sector >> Back to NEOG Financial Strength Comparisons >> Go to Compare NEOG Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q4 2026 to $916.90 millions, cumulative Quick Ratio decreased to 0.44 below the Neogen Corporation average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within In Vitro & In Vivo Diagnostic Substances industry 14 other companies have achieved higher Quick Ratio than Neogen. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2026 from 979 to 3959.

Explain Quick Ratio?
How much Cash & cash equivalents NEOG�s has?
What are NEOG�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the In Vitro & In Vivo Diagnostic Substances Industry	# 15
Healthcare Sector	# 893
Within the Market	# 3959

trailing twelve months Quick Ratio Statistics
High	Average	Low
2.43	1.65	0.8
(May 31 2013)		(Feb 28 2023)

Companies with similar Quick Ratio in the quarter ending May 31 2026, within In Vitro & In Vivo Diagnostic Substances Industry	Quick Ratio	May 31 2026 MRQ Cash & cash equivalent	May 31 2026 MRQ Current Liabilities
Biomerica Inc	0.53	$ 1.308 Millions	$ 2.481 Millions
Volitionrx Limited	0.21	$ 2.800 Millions	$ 13.493 Millions
Neogen Corporation	0.20	$ 185.500 Millions	$ 916.900 Millions
Idexx Laboratories Inc	0.15	$ 196.933 Millions	$ 1,287.665 Millions
Quidelortho Corp	0.12	$ 123.400 Millions	$ 993.400 Millions
Aspira Women s Health inc	0.09	$ 0.477 Millions	$ 5.338 Millions

Date modified: 2026-09-26T09:58:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.